COVID-19 Impact on Global Non-steroidal Anti-inflammatory Drugs(NSAID), Market Insights and Forecast to 2026

COVID-19 Impact on Global Non-steroidal Anti-inflammatory Drugs(NSAID), Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Introduction
1.2 Market Segments
1.3 Key Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by Type
1.4.2 Aspirin
1.4.3 Ibuprofen
1.4.4 Naproxen
1.4.5 Nabumetone
1.4.6 Others
1.5 Market by Application
1.5.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by Application
1.5.2 Back Pain Treatment
1.5.3 Osteoarthritis Treatment
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Non-steroidal Anti-inflammatory Drugs(NSAID) Industry Impact
1.6.1 How the Covid-19 is Affecting the Non-steroidal Anti-inflammatory Drugs(NSAID) Industry
1.6.1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Non-steroidal Anti-inflammatory Drugs(NSAID) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Non-steroidal Anti-inflammatory Drugs(NSAID) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Estimates and Forecasts
2.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue 2015-2026
2.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales 2015-2026
2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size by Region: 2020 Versus 2026
2.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Competitor Landscape by Players
3.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Manufacturers
3.1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Manufacturers (2015-2020)
3.1.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Manufacturers (2015-2020)
3.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Manufacturers
3.2.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Manufacturers (2015-2020)
3.2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue in 2019
3.2.5 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Price by Manufacturers
3.4 Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturing Base Distribution, Product Types
3.4.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type
3.4.3 Date of International Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs(NSAID) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size by Type (2015-2020)
4.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Type (2015-2020)
4.1.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Type (2021-2026)
4.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Type (2021-2026)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Type (2021-2026)
4.2.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size by Application (2015-2020)
5.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Application (2015-2020)
5.1.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Price by Application (2015-2020)
5.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Application (2021-2026)
5.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Application (2021-2026)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Application (2021-2026)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
6.1.1 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
6.1.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
6.3 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application
7 Europe
7.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
7.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) by Region
8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Region
8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
9.1.1 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
9.1.2 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
9.3 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) by Country
10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country
10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Type
10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.1.5 Bayer Recent Development
11.2 Novacap
11.2.1 Novacap Corporation Information
11.2.2 Novacap Description, Business Overview and Total Revenue
11.2.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.2.5 Novacap Recent Development
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Description, Business Overview and Total Revenue
11.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.3.5 Abbott Recent Development
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description, Business Overview and Total Revenue
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.4.5 Pfizer Recent Development
11.5 Geri-Care Pharmaceuticals
11.5.1 Geri-Care Pharmaceuticals Corporation Information
11.5.2 Geri-Care Pharmaceuticals Description, Business Overview and Total Revenue
11.5.3 Geri-Care Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.5.5 Geri-Care Pharmaceuticals Recent Development
11.6 Perrigo Company
11.6.1 Perrigo Company Corporation Information
11.6.2 Perrigo Company Description, Business Overview and Total Revenue
11.6.3 Perrigo Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.6.5 Perrigo Company Recent Development
11.7 Kopran
11.7.1 Kopran Corporation Information
11.7.2 Kopran Description, Business Overview and Total Revenue
11.7.3 Kopran Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.7.5 Kopran Recent Development
11.8 Merck Sharp & Dohme
11.8.1 Merck Sharp & Dohme Corporation Information
11.8.2 Merck Sharp & Dohme Description, Business Overview and Total Revenue
11.8.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.8.5 Merck Sharp & Dohme Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Corporation Information
11.9.2 Sun Pharmaceutical Industries Description, Business Overview and Total Revenue
11.9.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.9.5 Sun Pharmaceutical Industries Recent Development
11.10 Glaxo Smith Kline
11.10.1 Glaxo Smith Kline Corporation Information
11.10.2 Glaxo Smith Kline Description, Business Overview and Total Revenue
11.10.3 Glaxo Smith Kline Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.10.5 Glaxo Smith Kline Recent Development
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
11.1.5 Bayer Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Corporation Information
11.12.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.12.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Johnson & Johnson Products Offered
11.12.5 Johnson & Johnson Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Estimates and Projections by Region
12.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Regions 2021-2026
12.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Regions 2021-2026
12.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
12.2.1 North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
12.2.2 North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
12.2.3 North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)
12.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
12.3.1 Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
12.3.2 Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
12.3.3 Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Region (2021-2026)
12.5 Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
12.5.1 Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
12.5.2 Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
12.5.3 Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Non-steroidal Anti-inflammatory Drugs(NSAID) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Non-steroidal Anti-inflammatory Drugs(NSAID) Market Segments
Table 2. Ranking of Global Top Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Aspirin
Table 5. Major Manufacturers of Ibuprofen
Table 6. Major Manufacturers of Naproxen
Table 7. Major Manufacturers of Nabumetone
Table 8. Major Manufacturers of Others
Table 9. COVID-19 Impact Global Market: (Four Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Non-steroidal Anti-inflammatory Drugs(NSAID) Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Non-steroidal Anti-inflammatory Drugs(NSAID) Players to Combat Covid-19 Impact
Table 14. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Regions 2015-2020 (K MT)
Table 17. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Regions (2015-2020)
Table 18. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Manufacturers (2015-2020)
Table 21. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Non-steroidal Anti-inflammatory Drugs(NSAID) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-steroidal Anti-inflammatory Drugs(NSAID) as of 2019)
Table 23. Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Non-steroidal Anti-inflammatory Drugs(NSAID) Price (2015-2020) (USD/MT)
Table 26. Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type
Table 28. Date of International Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs(NSAID) Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020) (K MT)
Table 31. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Type (2015-2020)
Table 32. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Type (2015-2020)
Table 34. Non-steroidal Anti-inflammatory Drugs(NSAID) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020) (K MT)
Table 36. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Application (2015-2020)
Table 37. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country (2015-2020) (K MT)
Table 38. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Country (2015-2020)
Table 39. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Country (2015-2020)
Table 41. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020) (K MT)
Table 42. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2015-2020)
Table 43. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020) (K MT)
Table 44. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2015-2020)
Table 45. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country (2015-2020) (K MT)
Table 46. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Country (2015-2020)
Table 47. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Country (2015-2020)
Table 49. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020) (K MT)
Table 50. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2015-2020)
Table 51. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020) (K MT)
Table 52. Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2015-2020)
Table 61. Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country (2015-2020) (K MT)
Table 62. Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Country (2015-2020)
Table 65. Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020) (K MT)
Table 66. Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2015-2020)
Table 67. Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020) (K MT)
Table 68. Latin America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2015-2020)
Table 77. Bayer Corporation Information
Table 78. Bayer Description and Major Businesses
Table 79. Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Bayer Product
Table 81. Bayer Recent Development
Table 82. Novacap Corporation Information
Table 83. Novacap Description and Major Businesses
Table 84. Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Novacap Product
Table 86. Novacap Recent Development
Table 87. Abbott Corporation Information
Table 88. Abbott Description and Major Businesses
Table 89. Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Abbott Product
Table 91. Abbott Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Major Businesses
Table 94. Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Geri-Care Pharmaceuticals Corporation Information
Table 98. Geri-Care Pharmaceuticals Description and Major Businesses
Table 99. Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Geri-Care Pharmaceuticals Product
Table 101. Geri-Care Pharmaceuticals Recent Development
Table 102. Perrigo Company Corporation Information
Table 103. Perrigo Company Description and Major Businesses
Table 104. Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Perrigo Company Product
Table 106. Perrigo Company Recent Development
Table 107. Kopran Corporation Information
Table 108. Kopran Description and Major Businesses
Table 109. Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Kopran Product
Table 111. Kopran Recent Development
Table 112. Merck Sharp & Dohme Corporation Information
Table 113. Merck Sharp & Dohme Description and Major Businesses
Table 114. Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Merck Sharp & Dohme Product
Table 116. Merck Sharp & Dohme Recent Development
Table 117. Sun Pharmaceutical Industries Corporation Information
Table 118. Sun Pharmaceutical Industries Description and Major Businesses
Table 119. Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Sun Pharmaceutical Industries Product
Table 121. Sun Pharmaceutical Industries Recent Development
Table 122. Glaxo Smith Kline Corporation Information
Table 123. Glaxo Smith Kline Description and Major Businesses
Table 124. Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Glaxo Smith Kline Product
Table 126. Glaxo Smith Kline Recent Development
Table 127. Reddy Pharmaceuticals Corporation Information
Table 128. Reddy Pharmaceuticals Description and Major Businesses
Table 129. Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Reddy Pharmaceuticals Product
Table 131. Reddy Pharmaceuticals Recent Development
Table 132. Johnson & Johnson Corporation Information
Table 133. Johnson & Johnson Description and Major Businesses
Table 134. Johnson & Johnson Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 135. Johnson & Johnson Product
Table 136. Johnson & Johnson Recent Development
Table 137. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Regions (2021-2026) (K MT)
Table 138. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share Forecast by Regions (2021-2026)
Table 139. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 140. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share Forecast by Regions (2021-2026)
Table 141. North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Country (2021-2026) (K MT)
Table 142. North America: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Country (2021-2026) (K MT)
Table 144. Europe: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Region (2021-2026) (K MT)
Table 146. Asia Pacific: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 147. Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Country (2021-2026) (K MT)
Table 148. Latin America: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Country (2021-2026) (K MT)
Table 150. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 152. Key Challenges
Table 153. Market Risks
Table 154. Main Points Interviewed from Key Non-steroidal Anti-inflammatory Drugs(NSAID) Players
Table 155. Non-steroidal Anti-inflammatory Drugs(NSAID) Customers List
Table 156. Non-steroidal Anti-inflammatory Drugs(NSAID) Distributors List
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs(NSAID) Product Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type in 2020 & 2026
Figure 3. Aspirin Product Picture
Figure 4. Ibuprofen Product Picture
Figure 5. Naproxen Product Picture
Figure 6. Nabumetone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application in 2020 & 2026
Figure 9. Back Pain Treatment
Figure 10. Osteoarthritis Treatment
Figure 11. Others
Figure 12. Non-steroidal Anti-inflammatory Drugs(NSAID) Report Years Considered
Figure 13. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size 2015-2026 (US$ Million)
Figure 14. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales 2015-2026 (K MT)
Figure 15. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Region (2015-2020)
Figure 17. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Region in 2019
Figure 18. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Region (2015-2020)
Figure 19. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Region in 2019
Figure 20. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue in 2019
Figure 22. Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2015-2020)
Figure 24. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type in 2019
Figure 25. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Type (2015-2020)
Figure 26. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Type in 2019
Figure 27. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Price Range (2015-2020)
Figure 28. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2015-2020)
Figure 29. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application in 2019
Figure 30. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Application (2015-2020)
Figure 31. Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Application in 2019
Figure 32. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Country in 2019
Figure 35. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Country in 2019
Figure 36. U.S. Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Non-steroidal Anti-inflammatory Drugs(NSAID) Ma

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Methylprednisolone Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......

Global Ibuprofen Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......

Global Mesalazine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......

Global Drugs For Sinusitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......

Global Celecoxib Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......

Global Ibuprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100

According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Ketoprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114

Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......

Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91

According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs